Research output per year
Research output per year
Fingerprint
Dive into the research topics where Louise Lescrauwaet is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Erratum to: Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma
Duerinck, J., Lescrauwaet, L. & Dirven, I., 1 Apr 2026, In: Neuro-oncology. 28, 4, p. e2-e2 1 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Neurosurgeons’ perspective on surgical treatment of glioblastoma: Practices, beliefs and willingness to randomize in surgical trials
Duerinck, J., Lescrauwaet, L., Karschnia, P., Alfayate, R. P., Jenkinson, M. D., Molina, E. S., Simon, M., Gerritsen, J., Van Der Veken, J., Picart, T., Le Rhun, E., Minniti, G., Preusser, M., Weller, M., Wittens, M. M. J., Jakola, A. S. & Mansouri, A., 1 Jan 2026, In: Neuro-oncology advances. 8, 1, 14 p., vdag166.Research output: Contribution to journal › Article › peer-review
Open Access -
A phase I clinical trial on combined (neo-)adjuvant intravenous plus intracranial administration of ipilimumab and nivolumab in recurrent glioblastoma (NEOGLITIPNI).
Dirven, I., Lescrauwaet, L., Cleo, B., Stevens, L., Geeraerts, X., Vaeyens, F. (Contributor), Vanbinst, A., Everaert, H., Brock, S., Tuyaerts, S., Kockx, M., Duerinck, J. & Neyns, B., Jun 2025, In: Journal of Clinical Oncology. 43, 16, 1 p.Research output: Contribution to journal › Meeting abstract (Journal)
-
A phase I clinical trial on combined (neo-) adjuvant intravenous plus intracranial administration of ipilimumab and nivolumab in recurrent glioblastoma (NEO-GLITIPNI).
Dirven, I., Lescrauwaet, L., Bertels, C., Stevens, L., Geeraerts, X., Vaeyens, F., Vanbinst, A.-M., Everaert, H., Brock, S. & Tuyaerts, S., 2025, American Society of Clinical Oncology.Research output: Other contribution
-
Immunohistochemical and gene expression profiles as predictors of survival in recurrent high-grade glioma treated with intracranial nivolumab, ipilimumab, and autologous CD1c(BDCA-1)+/CD141(BDCA-3)+ myeloid dendritic cells (myDC)
Cleo, B., Dirven, I., Stevens, L., Geeraerts, X., Lescrauwaet, L., Geens, W., Del'haye, J., Brock, S., Vanbinst, A., Everaert, H., Vaeyens, F., Tuyaerts, S., Kockx, M., Duerinck, J. & Neyns, B., 28 May 2025, In: Journal of Clinical Oncology. 43, 16, 1 p., 2071.Research output: Contribution to journal › Meeting abstract (Journal)
Open Access
-
BANO 2024
Lescrauwaet, L. (Speaker)
6 Dec 2024Activity: Talk or presentation › Talk or presentation at a conference
-
Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma
Lescrauwaet, L. (Speaker)
18 Oct 2024Activity: Talk or presentation › Talk or presentation at a conference
-
Avondseminarie Heelkunde
Lescrauwaet, L. (Participant), Ledegen, L. (Participant), Gallala, S. (Participant), Vanhoeij, M. (Organiser), Karyouhi, A. (Participant), Langenberg, L. E. C. (Participant), Gomes, S. (Participant) & Vanwelssenaers, R. (Participant)
13 Mar 2024Activity: Participating in or organising an event › Participation in workshop, seminar
-
Avondseminarie Heelkunde: How to brief a Patient
Belhaj, A. (Organiser), Arts, S. (Organiser), Vanhoeij, M. (Chair), Langenberg, L. E. C. (Participant), Karyouhi, A. (Participant), Van Asbroeck, E. (Participant), Vounckx, M. (Participant), Blanckaert, M. (Participant), Vanwelssenaers, R. (Participant), Lescrauwaet, L. (Participant), Ledegen, L. (Participant), Vanderlinden, K. (Participant), Van Eetvelde, E. (Participant), Poortmans, N. K. N. (Participant) & Schoneveld, M. (Participant)
3 Jul 2024Activity: Participating in or organising an event › Participation in workshop, seminar
-
Avondseminarie Heelkunde: Galbladder and biliary disease (sprekers)
Ledegen, L. (Participant), Lescrauwaet, L. (Participant), Deleuze, J. M. M. (Participant), Vounckx, M. (Participant), Poortmans, N. K. N. (Participant), Schoneveld, M. (Participant), Van Praet, L. (Participant), Goyens, M. (Participant), Karyouhi, A. (Participant), Tuypens, J. (Participant), Vanwelssenaers, R. (Participant), Stockmans, A. (Participant), Van Asbroeck, E. (Participant) & Vanhoeij, M. (Organiser)
29 Nov 2023Activity: Participating in or organising an event › Participation in workshop, seminar